Bio-Techne Corporation (TECH)
NASDAQ · Healthcare
Bio-Techne Corporation Operating Income 2009–2025
Bio-Techne Corporation annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Bio-Techne Corporation operating income for the quarter ending March 31, 2026 was 75.5 M, a 95.04% increase year-over-year.
- Bio-Techne Corporation operating income for the twelve months ending March 31, 2026 was 216.3 M, a 12.43% increase year-over-year.
- Bio-Techne Corporation annual operating income for 2025 was 102.3 M, a 50.53% decrease from 2024.
- Bio-Techne Corporation annual operating income for 2024 was 206.7 M, a 30.86% decrease from 2023.
- Bio-Techne Corporation annual operating income for 2023 was 298.9 M, a 0.79% increase from 2022.
- Bio-Techne Corporation annual operating income for 2022 was 296.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bio-Techne Corporation Operating Income — FAQ
Bio-Techne Corporation (TECH) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Bio-Techne Corporation's operating income?
Bio-Techne Corporation (TECH) reported operating income of $102M for fiscal 2025.
Where can I see TECH's operating income history?
The chart and table above show Bio-Techne Corporation's operating income by year and by quarter, including the growth rate.